NFL-SLBP01

N/A

Report date: 2023/05/26 16:25:11

Base Information

Drug NameNFL-SLBP01
Drug Alias NameNFL-SLBP01
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Yuanzhi Sanmu Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Yuanzhi Sanmu Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A